loader
Please Wait
Applying Filters...

Looking for Pharmaceutical Excipients offered by Microlex e.U? Find Anhydrous Lactose / Microlex® LCA 60.m or Calcium Chloride Excipient / Microlex® CAL-Inj 500 or Calcium Stearate / Microlex® CS-141, Microlex® CS-142 or Carboxymethyl cellulose sodium / Microlex® CMC H, Microlex® CMC L or Copovidone K25-31 / Microlex® C.PVD S600 to address your drug delivery challenges on PharmaCompass.

Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 6Capsule

02 11Cream / Lotion / Ointment

03 5Injectable / Parenteral

04 4Solution

05 23Tablet

filter clear-filterReset all filters

PharmaCompass

06

arrow
2024 ACI Convention
Not Confirmed

07

arrow
2024 ACI Convention
Not Confirmed

10

arrow
2024 ACI Convention
Not Confirmed

11

arrow
2024 ACI Convention
Not Confirmed

12

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Microlex e.U

Excipient Details : It is also suitable for both wet granulation and direct compression methods of tablet production. Microlex® crystalline grades are used in wet granulation and the spray dried forms are used in direct compression.

Pharmacopoeia Ref : Monograph- USP/NF, JP/JPE

Technical Specs : Milled; Also Available as Microlex® LCA 120.m, Microlex® LCA 200.m

Grade : Oral

arrow

Brand : MICROLEX® LCA 60.M

Applications : It is also suitable for both wet granulation and direct compression methods of tablet production. Microlex® crystalline grades are used in wet granulation and the spray dried forms are used in direct compression.

Pharmacopoeia Ref : Monograph- USP/NF, JP/JPE

Technical Specs : Milled; Also Available as Microlex® LCA 120.m, Microlex® LCA 200.m

Grade : Oral

arrow
blank

13

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Microlex e.U

Excipient Details : It is also suitable for both wet granulation and direct compression methods of tablet production. Microlex® crystalline grades are used in wet granulation and the spray dried forms are used in direct compression.

Pharmacopoeia Ref : Monograph- USP/NF, JP/JPE

Technical Specs : Sieved; Also Available as Microlex® LCM 180.s, Microlex® LCM 220.s

Grade : Oral

arrow

Brand : MICROLEX® LCM 120.S

Applications : It is also suitable for both wet granulation and direct compression methods of tablet production. Microlex® crystalline grades are used in wet granulation and the spray dried forms are used in direct compression.

Pharmacopoeia Ref : Monograph- USP/NF, JP/JPE

Technical Specs : Sieved; Also Available as Microlex® LCM 180.s, Microlex® LCM 220.s

Grade : Oral

arrow
blank

14

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Microlex e.U

Excipient Details : Lactose monohydrate is typically used for wet or dry granulation. During wet granulation, liquid binders or adhesives are added to the lactose and active mixture, usually by blending.

Pharmacopoeia Ref : Monograph- USP/NF, JP/JPE

Technical Specs : Milled; Also Available as Microlex® LCM 180.m, Microlex® LCM 200.m

Grade : Oral

arrow

Brand : MICROLEX® LCM 80.M

Applications : Lactose monohydrate is typically used for wet or dry granulation. During wet granulation, liquid binders or adhesives are added to the lactose and active mixture, usually by blending.

Pharmacopoeia Ref : Monograph- USP/NF, JP/JPE

Technical Specs : Milled; Also Available as Microlex® LCM 180.m, Microlex® LCM 200.m

Grade : Oral

arrow
blank

16

arrow
2024 ACI Convention
Not Confirmed

17

arrow
2024 ACI Convention
Not Confirmed

19

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Microlex e.U

Excipient Details : Use in a wide range of oral applications such as wet or dry granulation, excipient of choice for flash release forms.

Pharmacopoeia Ref : Monograph- Ph.Eur, USP/NF

Technical Specs : Available in different particle size as 25.µ, 50.µ, 180.µ

Grade : Topical, Oral

arrow

Brand : MICROLEX® MLP 520

Applications : Use in a wide range of oral applications such as wet or dry granulation, excipient of choice for flash release forms.

Pharmacopoeia Ref : Monograph- Ph.Eur, USP/NF

Technical Specs : Available in different particle size as 25.µ, 50.µ, 180.µ

Grade : Topical, Oral

arrow
blank

20

arrow
2024 ACI Convention
Not Confirmed

21

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Microlex e.U

Excipient Details : Higher specific surface area and a smaller median particle size. This product is preferred for more critical and very fine herbal formulations.

Pharmacopoeia Ref : Monograph- Ph.Eur, USP/NF

Technical Specs : Specific Surface Area-8-12 m2/g; Particle Size-5-9 µm

Grade : Oral

arrow

Brand : MICROLEX® MS-102

Applications : Higher specific surface area and a smaller median particle size. This product is preferred for more critical and very fine herbal formulations.

Pharmacopoeia Ref : Monograph- Ph.Eur, USP/NF

Technical Specs : Specific Surface Area-8-12 m2/g; Particle Size-5-9 µm

Grade : Oral

arrow
blank

22

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Microlex e.U

Excipient Details : Suitable for combination with the favourable crystalline. Designed for special formulations, as low and stable viscosity is required for tablet coatings, Supports a lower dissolution profile

Pharmacopoeia Ref : Monograph- Ph.Eur, USP/NF

Technical Specs : Specific Surface Area-6-8 m2/g; Particle Size-7-11 µm

Grade : Oral

arrow

Brand : MICROLEX® MS-103

Applications : Suitable for combination with the favourable crystalline. Designed for special formulations, as low and stable viscosity is required for tablet coatings, Supports a lower dissolution profile

Pharmacopoeia Ref : Monograph- Ph.Eur, USP/NF

Technical Specs : Specific Surface Area-6-8 m2/g; Particle Size-7-11 µm

Grade : Oral

arrow
blank

23

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed
blank

24

arrow
2024 ACI Convention
Not Confirmed

25

arrow
2024 ACI Convention
Not Confirmed

26

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed
blank

27

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed
blank

28

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed
blank

29

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed
blank

30

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed
blank

32

arrow
2024 ACI Convention
Not Confirmed

33

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Brand : MICROLEX® SE 40

Applications : Sorbitan esters and their ethoxylates are a range of mild nonionic surfactants with multifunctional benefits in a number of healthcare applications.

Pharmacopoeia Ref : Monograph- Ph.Eur, USP/NF, FDA IIG

Technical Specs : Not Available

Grade : Topical, Oral

arrow
blank

34

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed
blank

35

arrow
2024 ACI Convention
Not Confirmed

36

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed
blank

37

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed
blank

38

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed
blank

39

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed
blank